Advertisement

Related Videos

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Advertisement

Advertisement




Aug
27
Today In Oncology
Cleveland Clinic President Discusses AI Summit for Health-Care Professionals
Dr. Gary R. Morrow, a Pioneer in Cancer Research, Dies at 82
FDA Approves Zanidatamab Combination Regimens for HER2 Gastric GEJ or Esophageal Cancer
ASCO Remembers Supportive Care and Symptom Management Pioneer Gary R. Morrow, PhD, MS
FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo